Sahajanand Medical Technologies (SMT), a prominent global innovator in cardiovascular medical devices, has announced the induction of Harvinder Singh as an Independent Director and Priyanka Dhirajlal Cohen as a Director on its Board.
Harvinder Singh currently serves as Executive Vice President and President, International, at Integra LifeSciences. With extensive leadership experience in the MedTech industry, including key roles at Abbott Laboratories, Singh brings deep expertise in commercial strategy and global market expansion. His appointment is expected to play a vital role in advancing SMT’s international growth agenda and commercial innovation initiatives.
Joining the Board as a Promoter-Director, Priyanka Dhirajlal Cohen brings a robust legal and governance background. A seasoned trial attorney, she has held positions at the U.S. Department of Justice and the District of Columbia Court of Appeals. Her addition enhances the Board’s legal acumen and strengthens SMT’s commitment to strong corporate governance.
Welcoming the new appointments, Jose Calle Gordo, Chairman of SMT, said, “Harvinder and Priyanka bring unique and complementary strengths to SMT. Their combined experience in international business strategy and legal governance aligns with our innovation-driven mission and will be instrumental in guiding our next phase of growth.”
These strategic additions to the board reinforce SMT’s vision of delivering cutting-edge cardiovascular solutions while upholding the highest standards in governance and global leadership.